Vice President, Head of Global Translational Medicine & Research

Genmab Translational Medicine & Research Team Leader

At Genmab, we are dedicated to building extraordinary futures, together, by developing antibody products and groundbreaking antibody medicines that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals' unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.

Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.

Does this inspire you and feel like a fit? Then we would love to have you join us!

The Role

As the Vice President, Head of Translational Medicine & Research, you will lead a global organization of 60+ scientists based in the US and the Netherlands. The team spans a broad spectrum of capabilities (including a translational lab in NL) and plays a pivotal role in shaping translational strategies from discovery through late-stage clinical development.

The Global Head of Translational Medicine & Research (TM&R) will report to the Head of Translational & Quantitative Sciences. You will represent TM&R on the Translational & Quantitative Sciences Leadership Team and be responsible for :

• Providing scientific and strategic direction for the delivery of comprehensive pre-clinical and clinical translational data packages and derived insights, ensuring alignment with organizational goals and regulatory standards.
• Advancing biomarker strategies and applying insights to clinical development.
• Driving innovation, scientific excellence, and team development.
• Acting as an ambassador of Genmab science in both internal and external forums.

This is an exciting opportunity to lead a passionate, high profile, high-impact translational team, and work in a highly dynamic and collaborative setting.

We have a hybrid model that requires being onsite 60% of the time in Princeton, NJ or Utrecht, NL.

Responsibilities

Strategic and scientific leadership

External engagement

Team development

Qualifications

Compensation and Benefits

The proposed salary band for this position is as follows : $266,640.00 $399,960.00. The actual salary offer will carefully consider a wide range of factors, including your skills, qualifications, experience, and location. Also, certain positions are eligible for additional forms of compensation, such as discretionary bonuses and long-term incentives.

When you join Genmab, you're joining a culture that supports your physical, financial, social, and emotional wellness. Within the first year, regular full-time U.S. employees are eligible for :

About You

Locations

Genmab maximizes the efficiency of an agile working environment, when possible, for the betterment of employee work-life balance. Our offices are crafted as open, community-based spaces that work to connect employees while being immersed in our powerful laboratories. Whether you're in one of our office spaces or working remotely, we thrive on connecting with each other to innovate.

About Genmab

Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab's vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific.